Benitec Biopharma (BNTC)

• Market cap: $397M
• 1 day: -0.26%
• 5 days: -2.59%
• 1 month: -5.88%
• 3 months: -25.61%
• 6 months: -0.6%
• Year to date: -7.23%
• 1 year: 5.61%
• 5 years: -81.07%
• 10 years: -98.83%
• Sector: Healthcare
• Industry: Biotechnology

About: Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Employees: 19